Announcements

Job Offers

Top 5 -yesterday

Top 5 -last week

Top 5 -last month

JMCC Group expands global medical cannabis distribution network with Australasia partnership

JMCC Group has signed an agreement with Sativite Pty to distribute JMCC medical cannabis products throughout Australia, New Zealand and other countries in the region.

The deal follows the announcement of another last week on the formation of JMCC European Distribution Limited in the Channel Island of Jersey to expedite medical cannabis deliveries to Europe and the United Kingdom. The new partnership extends the company’s self-managed supply chain to ensure plant-to-patient control over product quality, safety and security for patients and business customers in Australasia.

JMCC is the only Canadian private medical cannabis company to own its entire supply chain.

“We have been focused on creating a fully integrated medical cannabis company and determining how to expand our distribution network was the final step. Having served the Australian market from Toronto for the past few years, it was clear that our growth required us to think differently. This partnership is a perfect addition to our model for reaching patients worldwide,” said Ms. Scott.

Ms. Scott initially met some of the founders of what was to become Sativite Pty three years ago at Toronto’s Lift Conference & Expo, and says she is thrilled the long relationship had finally culminated in the opportunity to work more closely together. One of those founders was Brian White, now a Director and Chief Technical Officer with Sativite.

“You could call it a long courtship, “Mr. White said. “From the start, we were interested in doing business with JMCC in some way as our values are so well aligned. The stars finally aligned too and we’re delighted to now be representing JMCC in this part of the world.”

Sativite CEO Mike Cleary said he’s excited his company was selected to distribute JMCC’s products to countries throughout the region that have legalized cannabis for medicinal use.

“As patients ourselves, the entire executive team is committed to delivering the most high-quality and affordable medicinal cannabis products available from Australia and around the world to pharmacies and patients in the region. This partnership enables us to add pharma-grade, Jamaican products to our offering, and from a company that is as passionate about quality, safety and sustainability as we are.”

For more information:
JMCC
Shelley Boyes
Global Marketing & Communications Director
T: +1 416.272.8981
E: shelley.boyes@jamaicanmedicann.com 

Andrea Chrysanthou
Global Public Affairs
T: +1 416.797-8194
E: achrysanthou@globalpublic.com 


Publication date:



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


Twitter Rss

© MMJDaily.com 2021

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber